Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Growth 2025-2031

Global Pharmaceutical Grade Polyethylene Glycol (PEG) Market Growth 2025-2031

The global Pharmaceutical Grade Polyethylene Glycol (PEG) market size is predicted to grow from US$ 844 million in 2025 to US$ 1143 million in 2031; it is expected to grow at a CAGR of 5.2% from 2025 to 2031.

Polyethylene glycol (PEG) is a polyether compound with many applications from industrial manufacturing to medicine. PEG also known as polyethylene oxide (PEO) or polyoxyethylene (POE), depending on its molecular weight. The structure of PEG is commonly expressed as H−(O−CH2−CH2)n−OH, n indicating the average number of oxyethylene groups. In this report, we mainly focus on the application of PEG with molecular mass within 10,000 g/mol in the pharmaceutical field.

The global Pharmaceutical Grade Polyethylene Glycol (PEG) market is experiencing steady growth, driven by its widespread application in the pharmaceutical, biotechnology, and personal care industries. PEG is valued for its versatility, biocompatibility, and non-toxicity, making it an essential component in a variety of drug formulations.

1. Growth in the Biopharmaceutical Sector

PEGylation: PEG is widely used in biopharmaceuticals through a process known as PEGylation, where PEG chains are attached to therapeutic molecules like proteins or peptides to enhance their stability, reduce immunogenicity, and extend their half-life. With the increasing development of biologics and biosimilars, the demand for PEG in these applications is rising.

Monoclonal Antibodies and Proteins: The growing use of monoclonal antibodies (mAbs) and therapeutic proteins in treating chronic diseases like cancer, autoimmune disorders, and genetic conditions is driving demand for PEG, which helps improve the pharmacokinetics of these drugs.

2. Increasing Application in Drug Delivery Systems

Oral, Injectable, and Topical Formulations: PEG is commonly used in various drug delivery systems, including oral, injectable, and topical formulations. Its solubility and ability to improve drug bioavailability make it a preferred excipient in many pharmaceutical products. The rising demand for innovative drug delivery systems is boosting the PEG market.

Controlled and Sustained Release Formulations: PEG is also used in controlled-release formulations to enhance drug stability and modulate the release of active ingredients. As the pharmaceutical industry focuses on developing long-acting formulations, the role of PEG in these systems is expanding.

4. Expansion in the Pharmaceutical Industry

Pharmaceutical Excipients: PEG serves as an important excipient in a wide range of pharmaceutical formulations, including tablets, capsules, and ointments. Its role in improving drug solubility and absorption is critical, particularly for poorly soluble drugs. The continued growth of the pharmaceutical industry, driven by an aging population and the rise in chronic diseases, is contributing to increased demand for pharmaceutical-grade PEG.

Over-the-Counter (OTC) Medications: PEG is commonly used in laxatives and stool softeners. With the increase in the prevalence of gastrointestinal issues and other digestive disorders, particularly in developed markets, the demand for PEG-based OTC medications is growing.

5. Growing Focus on Sustainable and Bio-Based PEG

Sustainability Initiatives: There is an increasing trend toward using bio-based PEG derived from renewable resources due to growing environmental concerns and regulations. Manufacturers are focusing on developing eco-friendly, sustainable alternatives to traditional petrochemical-based PEG, which is expected to gain traction in the pharmaceutical and personal care industries.

Regulatory Compliance: With the tightening of environmental and safety regulations in several regions, the focus on green chemistry and sustainable production methods is becoming more important. Companies investing in the production of bio-based or biodegradable PEG will benefit from this shift.

LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Grade Polyethylene Glycol (PEG) Industry Forecast” looks at past sales and reviews total world Pharmaceutical Grade Polyethylene Glycol (PEG) sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Grade Polyethylene Glycol (PEG) sales for 2025 through 2031. With Pharmaceutical Grade Polyethylene Glycol (PEG) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Grade Polyethylene Glycol (PEG) industry.

This Insight Report provides a comprehensive analysis of the global Pharmaceutical Grade Polyethylene Glycol (PEG) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Grade Polyethylene Glycol (PEG) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Grade Polyethylene Glycol (PEG) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Grade Polyethylene Glycol (PEG) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Grade Polyethylene Glycol (PEG).

This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Grade Polyethylene Glycol (PEG) market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Mw (＜1000)
Mw (1000-10000)

Segmentation by Application:
Tablets
Capsules
Liquids
Injectables
Topicals
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
BASF
Dow Chemical
Croda
Clariant
Ineos
India Glycols
Shandong Ruisheng
Jiangxi Yipusheng
Liaoning Huaxing Chemical
Petronas Chemicals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pharmaceutical Grade Polyethylene Glycol (PEG) market?

What factors are driving Pharmaceutical Grade Polyethylene Glycol (PEG) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pharmaceutical Grade Polyethylene Glycol (PEG) market opportunities vary by end market size?

How does Pharmaceutical Grade Polyethylene Glycol (PEG) break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.